Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer
| المؤلف | Tkac J. |
| المؤلف | Gajdosova V. |
| المؤلف | Hroncekova S. |
| المؤلف | Bertok T. |
| المؤلف | Hires M. |
| المؤلف | Jane E. |
| المؤلف | Lorencova L. |
| المؤلف | Kasak P. |
| تاريخ الإتاحة | 2020-04-09T12:27:28Z |
| تاريخ النشر | 2019 |
| اسم المنشور | Interface Focus |
| المصدر | Scopus |
| الرقم المعياري الدولي للكتاب | 20428898 |
| الملخص | The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence). |
| راعي المشروع | acknowledge the support received from the ERC Proof of Concept grant (no. 825586) and from the Innovative Training Network (no. 813120). This publication is the result of the project implementation: Centre for materials, layers and systems for applications and chemical processes under extreme conditions stage I, ITMS no.: 26240120007, supported by the ERDF. |
| اللغة | en |
| الناشر | Royal Society Publishing |
| الموضوع | Biomarkers Diagnostics Glycans Lectins Prostate cancer Prostate-specific antigen |
| النوع | Article Review |
| رقم العدد | 2 |
| رقم المجلد | 9 |
الملفات في هذه التسجيلة
| الملفات | الحجم | الصيغة | العرض |
|---|---|---|---|
|
لا توجد ملفات لها صلة بهذه التسجيلة. |
|||
هذه التسجيلة تظهر في المجموعات التالية
-
الأبحاث [1327 items ]